Page 183 - Eceptor News Today

A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds.

Researchers from the Management and Science University in Malaysia have used computational tools to investigate the new variant.

A new study has focussed on determining the levels of nAb in individuals who received the second and third doses of the RNA vaccines developed by Pfizer and Moderna.

New study suggests that the SARS-CoV-2 ORF8 protein is the underlying cause behind severe COVID-19 infection.

New findings suggest that Macaque monkeys may not be the ideal model when testing for SARS-CoV-2.

In a new study, scientists have computationally predicted the structure of the Omicron spike RBD from available sequences and explored the dynamics of antigen-antibody interactions.

Researchers from the Rensselaer Polytechnic Institute have been investigating the potential of rhamnan sulfate as an antiviral agent.

In this interview, News-Medical speaks to Dr. Stupp ​​about his recent research into a therapy involving dancing molecules for the treatment of severe spinal cord injury.

The current study not only analyses the mutations in the Omicron spike variant but classifies various combinations of spike mutations into groups.

A new study provides understanding of the intricate roles and functions of the different elements of spike proteins and shows how the spike protein samples a crowded surface of its host cell via the glycans.